KOR

e-Article

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
Document Type
Article
Source
In Annals of Oncology June 2020 31(6):798-806
Subject
Onco-Immunology
Language
ISSN
0923-7534